INDmoney
Arrowhead Pharmaceuticals, Inc. Stock Performance
as on February 21, 2026 at 7:59 am IST
Day's Low
Day's High
$62.09$64.59
2.37%
Downside
1.56%
Upside
52 Week's Low
52 Week's High
$9.57$76.7684.95%
Downside
20.69%
Upside
Arrowhead Pharmaceuticals, Inc. share price movements today
- Previous Close
- $63.86
- Open
- $63.58
- Volume
- 2.2M
- Day's Low - High
- $62.09 - $64.59
- 52 Week Low - High
- $9.57 - $76.76
Arrowhead Pharmaceuticals, Inc. Historical Returns
- 1 Month Return
- -5.16 %
- 3 Month Return
- + 57.21 %
- 1 Year Return
- + 219.55 %
- 3 Year Return
- + 94.17 %
- 5 Year Return
- -22.21 %
Arrowhead Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators
Check Arrowhead Pharmaceuticals, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$8.9B
EPS (TTM)
-3.2391
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.10%
PE Ratio (TTM)
39.74
Industry PE ratio
5.983738317757009
PEG Ratio
-1.32
EBITDA
325.6M
Revenue (TTM)
1.1B
Profit Margin
18.54%
Return On Equity TTM
75.50%
Arrowhead Pharmaceuticals, Inc. Stock Valuation
Track how Arrowhead Pharmaceuticals, Inc. P/E has moved over time to understand its valuation trends.
Arrowhead Pharmaceuticals, Inc. in the last 5 years
Lowest (-72.52x)
March 31, 2021
Industry (5.98x)
February 23, 2026
Today (39.74x)
February 23, 2026
Highest (30.63x)
December 31, 2025
Today’s Price to Earnings Ratio: 39.74x
Arrowhead Pharmaceuticals, Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Arrowhead Pharmaceuticals, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $8.9B | -22.21% | 39.74 | 18.54% | |
| BUY | $44.6B | 119.43% | 144.91 | 8.45% | |
| BUY | $121.1B | 120.34% | 31.15 | 32.94% | |
| NA | $40.1B | NA | 710.08 | 1.38% | |
| BUY | $82.4B | 66.59% | 18.8 | 31.41% |
Stock Returns calculator for Arrowhead Pharmaceuticals, Inc. Stock including INR - Dollar returns
The Arrowhead Pharmaceuticals, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Arrowhead Pharmaceuticals, Inc. investment value today
Current value as on today
₹3,24,226
Returns
₹2,24,226
(+224.23%)
Returns from Arrowhead Pharmaceuticals, Inc. Stock
₹2,19,598 (+219.6%)
Dollar Returns*
₹4,628 (+4.63%)
Analyst Recommendation on Arrowhead Pharmaceuticals, Inc. Stock
Based on 20 analysts
75.00%
Buy
25.00%
Hold
0.00%
Sell
Based on 20 analysts, 75% of analysts recommend a 'BUY' rating for Arrowhead Pharmaceuticals, Inc.. Average target price of $81.36
Arrowhead Pharmaceuticals, Inc. Share Price Target
Get share price movements and forecasts by analysts on Arrowhead Pharmaceuticals, Inc..
What analysts predicted
21.83%UPSIDE
Target Price
$81.36
Current Price
$63.6
Analyzed by
20 Analysts
Target
$81.36
Arrowhead Pharmaceuticals, Inc. target price $81.36, a slight upside of 21.83% compared to current price of $63.6. According to 20 analysts rating.
Arrowhead Pharmaceuticals, Inc. Stock’s Investor Sentiment and Interest
Search interest for Arrowhead Pharmaceuticals, Inc. Stock has decreased by -29% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Arrowhead Pharmaceuticals, Inc. Quarterly Profit & Loss
All numbers in Millions USD
Arrowhead Pharmaceuticals, Inc. Annual Profit & Loss
All numbers in Millions USD
Arrowhead Pharmaceuticals, Inc. Quarterly Cash Flow
All numbers in Millions USD
Arrowhead Pharmaceuticals, Inc. Annual Cash Flow
All numbers in Millions USD
Arrowhead Pharmaceuticals, Inc. News & Key Events
Today's Timeline - 25 November
Tue, 11:38 PM
-Sarepta triggers a $200 million milestone payment to Arrowhead Pharmaceuticals as part of a licensing deal.
Wed, 02:48 AM
-Arrowhead Pharmaceuticals releases its 10-K report, showcasing improved financial performance and strategic initiatives in RNAi therapeutics.
Insights on Arrowhead Pharmaceuticals, Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 3 quarters, -175.24M → 30.81M (in $), with an average increase of 407.5% per quarter
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, ARWR has outperformed top 5 stocks with highest market-cap in its industry
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 27.76M → 264.03M (in $), with an average increase of 46.0% per quarter
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, ARWR has outperformed top 5 stocks with highest market-cap in its industry
- POSITIVE IMPACT
Price Rise
In the last 3 months, ARWR stock has moved up by 57.2%
About Arrowhead Pharmaceuticals, Inc.
| Organisation | Arrowhead Pharmaceuticals, Inc. |
| Headquarters | 177 East Colorado Boulevard, Pasadena, CA, United States, 91105 |
| Industry | Health Technology |
| CEO | Dr. Christopher R. Anzalone Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Arrowhead Pharmaceuticals, Inc.
Name | Title |
|---|---|
Dr. Bruce D. Given M.D. | Chief Medical Scientist |
Dr. Mark Seefeld | Head of Toxicology & VP |
Aaron Tan | Head of Tax |
Mr. Daniel J. Apel | Chief Financial Officer |
Mr. Patrick O'Brien J.D., PharmD | COO & Secretary |
Dr. Vincent Anzalone CFA | Head of Investor Relations & VP |
Mr. Howard Lovy | Director of Communications |
Dr. Christopher R. Anzalone Ph.D. | Chairman, CEO & President |
Dr. James C. Hamilton M.D., MBA | Chief Medical Officer and Head of R&D |
Dr. Mark M. Davis Ph.D. | Founder and Founder & Director of Insert Therapeutics Inc & Calando |
FAQs
What is Arrowhead Pharmaceuticals, Inc. share price today?
Arrowhead Pharmaceuticals, Inc. share price today is $63.6 as on at the close of the market. Arrowhead Pharmaceuticals, Inc. share today touched a day high of $64.59 and a low of $62.09.
What is the 52 week high and 52 week low for Arrowhead Pharmaceuticals, Inc. share?
Arrowhead Pharmaceuticals, Inc. share touched a 52 week high of $76.76 on and a 52 week low of $9.57 on . Arrowhead Pharmaceuticals, Inc. stock price today i.e. is closed at $63.6,which is 17.14% down from its 52 week high and 564.58% up from its 52 week low.
What is Arrowhead Pharmaceuticals, Inc.'s market capitalisation today?
Arrowhead Pharmaceuticals, Inc. market capitalisation is $0.01T as on .
How to invest in Arrowhead Pharmaceuticals, Inc. Stock (ARWR) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Arrowhead Pharmaceuticals, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Arrowhead Pharmaceuticals, Inc. Shares that will get you 0.0236 shares as per Arrowhead Pharmaceuticals, Inc. share price of $63.6 per share as on February 21, 2026 at 2:29 am IST.
What is the minimum amount required to buy Arrowhead Pharmaceuticals, Inc. Stock (ARWR) from India?
Indian investors can start investing in Arrowhead Pharmaceuticals, Inc. (ARWR) shares with as little as ₹90.681 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹906.81 in Arrowhead Pharmaceuticals, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Arrowhead Pharmaceuticals, Inc. share’s latest price of $63.6 as on February 21, 2026 at 2:29 am IST, you will get 0.1572 shares of Arrowhead Pharmaceuticals, Inc.. Learn more about
fractional shares .
What are the returns that Arrowhead Pharmaceuticals, Inc. has given to Indian investors in the last 5 years?
Arrowhead Pharmaceuticals, Inc. stock has given -22.21% share price returns and 25.66% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?